C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/805 (2006.01) C12N 1/21 (2006.01) C12N 15/12 (2006.01) C12P 21/02 (2006.01)
Patent
CA 2299049
The invention relates to novel recombinant hemoglobins having reduced nitric oxide scavenging and/or increased high soluble expression. The invention further relates to methods of increasing the soluble expression of recombinant hemoglobin by adding exogenous hemin in molar excess of the heme binding sites of recombinant hemoglobin.
L'invention concerne de nouvelles hémoglobines recombinantes ayant une évacuation réduite d'oxyde nitrique et/ou une expression soluble accrue. L'invention concerne également des procédés permettant d'augmenter l'expression soluble de l'hémoglobine recombinante par ajout d'hémine exogène en excès molaire des sites de liaison hème de l'hémoglobine recombinante.
Doherty Daniel H.
Glascock Christopher B.
Lemon Douglas D.
Mathews Antony J.
Olson John S.
Baxter Biotech Technology S.a.r.l.
Sim & Mcburney
William Marsh Rice University
LandOfFree
Hemoglobin mutants with increased soluble expression and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hemoglobin mutants with increased soluble expression and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemoglobin mutants with increased soluble expression and/or... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1888819